drugset / Trial / NCT06794450

Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade

NCT06794450

Phase 1/2 Recruiting 60 enrolled Padjadjaran University
RandomizedParallel-groupDouble-blindTreatment

Summary

In operating procedure with general anesthesia muscle relaxant is usually used to increase success rate of the operation and to give better outcome. The use of reversal drugs aims to reduce the risk of post-operative complications due to muscle relaxants. Neostigmine is commonly used as a reversal drug, but its indirect mechanism of action results in a long and unpredictable recovery time. Sugammadex directly bind and inactivate rocuronium, in which resulting in a faster and predictable recovery time. However, the high price limits the use of sugammadex. This study aims to compare the effect of half dose sugammadex and neostigmine against the moderate neuromuscular blockade of rocuronium. The main questions it aims to answer are: Does half dose sugammadex gives faster recovery time? Researchers will compare sugammadex to neostigmine to see if sugammadex gives faster recovery time. Participants will: Be given sugammadex or neostigmine as a reversal drug after the operation done

Timeline

Start
2024-11-05
Primary completion
2025-02
Completion
2025-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 60 ug/kg Intravenous
Subject Sugammadex Other / unclassified 1 mg/kg Intravenous
Comparator Atropine Other / unclassified 0.4 mg Intravenous